FRANKLIN STRATEGIC SERIES's FRANKLIN BIOTECHNOLOGY DISCOVERY FUND (FBDIX) has disclosed 84 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2025-04-30. The current portfolio value is calculated to be $690.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 5%.
FRANKLIN BIOTECHNOLOGY DISCOVERY FUND (FBDIX)'s
Total Assets is $714.89 Mil , Total Liabilities is $7.22 Mil , Net Assets is $707.67 Mil.
In FRANKLIN BIOTECHNOLOGY DISCOVERY FUND (FBDIX)'s current portfolio as of 2025-04-30, the top 5 holdings are
Vertex Pharmaceuticals Inc (VRTX), Gilead Sciences Inc (GILD), Amgen Inc (AMGN), Regeneron Pharmaceuticals Inc (REGN) and Ascendis Pharma AS (ASND),
not including call and put options.
FRANKLIN BIOTECHNOLOGY DISCOVERY FUND (FBDIX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for FRANKLIN BIOTECHNOLOGY DISCOVERY FUND (FBDIX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for FRANKLIN BIOTECHNOLOGY DISCOVERY FUND (FBDIX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for FRANKLIN BIOTECHNOLOGY DISCOVERY FUND.